Choice of hormonal therapy for prostate cancer

被引：20

作者：

Reese, DM ^{[1
]}

机构：

[1] Univ Calif San Francisco, Mt Zion Med Ctr, Urol Oncol Program, San Francisco, CA 94115 USA

来源：

LANCET | 2000年 / 355卷 / 9214期

关键词：

D O I：

10.1016/S0140-6736(00)02155-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1474 / 1475

页数：2

共 12 条

[1] A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer [J].

Bales, GT ;

Chodak, GW .

UROLOGY, 1996, 47 (1A) :38-43

[2] Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: Results of an Italian Prostate Cancer Project study [J].

Boccardo, F ;

Rubagotti, A ;

Borichello, M ;

Battaglia, M ;

Carmignani, G ;

Comeri, G ;

Conti, G ;

Cruciani, G ;

Dammino, S ;

Delliponti, U ;

Ditonno, P ;

Ferraris, V ;

Lilliu, S ;

Montefiore, F ;

Portoghese, F ;

Spano, G .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2027-2038

[3]

DALESIO O, 1995, LANCET, V346, P265

[4] PROSTATE-SPECIFIC ANTIGEN AFTER GONADAL ANDROGEN WITHDRAWAL AND DEFERRED FLUTAMIDE TREATMENT [J].

FOWLER, JE ;

PANDEY, P ;

SEAVER, LE ;

FELIZ, TP .

JOURNAL OF UROLOGY, 1995, 154 (02) :448-453

[5]

Huggins C, 1941, CANCER RES, V1, P293

[6] Studies on prostate cancer II The effects of castration on advanced carcinoma of the prostate gland [J].

Huggins, C ;

Stevens, RE ;

Hodges, CV .

ARCHIVES OF SURGERY, 1941, 43 (02) :209-223

[7]

LABRIE F, 1982, CLIN INVEST MED, V5, P267

[8]

LABRIE F, 1995, LANCET, V346, P1031

[9]

QUARTEY P, 1995, LANCET, V346, P1031

[10] Prostate cancer treated by anti-androgens:: is sexual function preserved? [J].

Schröder, FH ;

Collette, L ;

de Reijke, TM ;

Whelan, P .

BRITISH JOURNAL OF CANCER, 2000, 82 (02) :283-290

← 1 2 →